News
4don MSNOpinion
In a Kansas City Star guest commentary (6/25/25 page 14A), Jamie Corley, executive director of the nonprofit Prescription ...
PBMs argue that as middlemen between large pharmaceutical companies and consumers, they save patients money. Middlemen contend that critics have cherry-picked cases while “completely ...
Kentucky’s independent pharmacies, facing ongoing financial pressure, had hoped for relief from a new law meant to give them ...
CMS chief Mehmet Oz, MD, is calling on the nation’s largest pharmacy benefit managers to voluntarily abandon the current drug rebate model, or risk its elimination by the government, Bloomberg ...
Hosted on MSN11mon
Alternative PBMs Arise to Compete With the 'Big Three'A Different Model. But these alternative PBMs operate in a different way -- they charge a flat per-member-per-month fee to employers and then pass along 100% of rebates to them, which they contend ...
T he three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of acquisition, earning more than $7.3 billion in revenue from 2017 to 2022 ...
President Donald Trump has signed two executive orders aimed at reducing the cost of prescription drugs, but pharmaceutical benefit managers have been a small part of the legislation. Here’s what to k ...
PBMs act as an intermediary on behalf of plan sponsors (e.g., employers) to negotiate lower drug prices from brand manufacturers and lower prices at the pharmacy.
The PBMs do not reimburse pharmacies for these transactions, meaning the patients' cash payment represents the pharmacies' only revenue, and PBMs' profits increase, the lawsuits say.
Insights on ways pharmacy benefit managers can tap earned media to enhance their reputation—and demonstrate value through ...
PBMs also faced questions on group purchasing organizations, or groups that leverage purchasing power to negotiate drug prices. From 2019 to 2021, the big three PBMs established locations overseas.
A heated debate over the U.S. healthcare system erupted on X, pitting billionaire entrepreneur Mark Cuban against Sen.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results